CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
Endowave has developed a minimally invasive device to treat lung cancer by delivering targeted microwave heating to tumors. This innovative technology aims to improve patient outcomes and reduce healthcare costs by enabling outpatient treatments.
Lung cancer is the most common cause of cancer deaths in the EU and worldwide with more than 0.4M people diagnosedeach year.
It has a dismal 5 year survival rate of just 18% and worldwide someone dies of lung cancer every 30 seconds.The impact of the disease on public health is substantial with > 6M hospital admissions in Europe each year (>€18 billion ineconomic costs).
Surgery has been shown to provide a curative solution, but only 20-30% of patients can undergo surgerydue to co-morbidities.En…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Switzerland, HERISAU
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Ireland, Galway
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Italy, Ruvo Di Puglia Ba
Type: SME
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: Yes
TELEFLEX MEDICAL EUROPE LIMITED
Ireland, Athlone Co. Westmeath
Type: Company (for-profit)
Activity type: Private for-profit entities (excluding Higher or Secondary Education Establishments)
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
